These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22122015)

  • 1. Final height in a prospective trial of late steroid withdrawal after pediatric renal transplantation treated with cyclosporine and mizoribine.
    Motoyama O; Hasegawa A; Aikawa A; Shishido S; Honda M; Tsuzuki K; Kinukawa T; Hattori M; Ogawa O; Yanagihara T; Saito K; Takahashi K; Ohshima S
    Pediatr Transplant; 2012 Feb; 16(1):78-82. PubMed ID: 22122015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective trial of steroid withdrawal after renal transplantation treated with cyclosporine and mizoribine in children: results obtained between 1990 and 2003.
    Motoyama O; Hasegawa A; Ohara T; Satoh M; Shishido S; Honda M; Tsuzuki K; Kinukawa T; Hattori M; Ito K; Ogawa O; Yanagihara T; Saito K; Takahashi K; Ohshima S
    Pediatr Transplant; 2005 Apr; 9(2):232-8. PubMed ID: 15787799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective trial of steroid withdrawal after renal transplantation in children: results obtained 1990 and 2002.
    Hasegawa A; Motoyama O; Shishido S; Ito K; Tsuzuki K; Takahashi K; Ohshima S
    Transplant Proc; 2004 Mar; 36(2 Suppl):216S-219S. PubMed ID: 15041340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective trial of steroid cessation after renal transplantation in pediatric patients treated with cyclosporine and mizoribine.
    Motoyama O; Hasegawa A; Ohara T; Hattori M; Kawaguchi H; Takahashi K; Kamiyama Y; Nakai H; Shishido S; Ogawa O; Kawamura T; Tsuzuki K; Oshima S
    Pediatr Transplant; 1997 Aug; 1(1):29-36. PubMed ID: 10084784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil.
    Höcker B; Weber LT; Feneberg R; Drube J; John U; Fehrenbach H; Pohl M; Zimmering M; Fründ S; Klaus G; Wühl E; Tönshoff B
    Transplantation; 2009 Mar; 87(6):934-41. PubMed ID: 19300199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of growth and body mass index after pediatric renal transplantation.
    Vester U; Schaefer A; Kranz B; Wingen AM; Nadalin S; Paul A; Malagò M; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2005 Aug; 9(4):445-9. PubMed ID: 16048595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final height in children with steroid-sensitive nephrotic syndrome.
    Motoyama O; Iitaka K
    Pediatr Int; 2007 Oct; 49(5):623-5. PubMed ID: 17875088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved growth and cardiovascular risk after late steroid withdrawal: 2-year results of a prospective, randomised trial in paediatric renal transplantation.
    Höcker B; Weber LT; Feneberg R; Drube J; John U; Fehrenbach H; Pohl M; Zimmering M; Fründ S; Klaus G; Wühl E; Tönshoff B
    Nephrol Dial Transplant; 2010 Feb; 25(2):617-24. PubMed ID: 19793929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of growth after kidney transplantation among children with ESRD.
    Franke D; Thomas L; Steffens R; Pavičić L; Gellermann J; Froede K; Querfeld U; Haffner D; Živičnjak M
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):127-34. PubMed ID: 25352379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression with low-dose cyclosporine, mizoribine, and steroids in living-related kidney transplantation.
    Takeuchi N; Ohshima S; Matsuura O; Ono Y; Katoh N; Yamada S; Fujita T; Kinukawa T; Hirabayashi S; Sahashi M
    Transplant Proc; 1994 Aug; 26(4):1907-9. PubMed ID: 8066621
    [No Abstract]   [Full Text] [Related]  

  • 12. Normal adult height after steroid-withdrawal within 6 months of pediatric kidney transplantation: a 20 years single center experience.
    Klare B; Montoya CR; Fischer DC; Stangl MJ; Haffner D
    Transpl Int; 2012 Mar; 25(3):276-82. PubMed ID: 22187956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine.
    Pelletier RP; Akin B; Ferguson RM
    Clin Transplant; 2006; 20(1):10-8. PubMed ID: 16556147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid withdrawal after pediatric liver transplantation: a long-term follow-up study in 109 recipients.
    Diem HV; Sokal EM; Janssen M; Otte JB; Reding R
    Transplantation; 2003 May; 75(10):1664-70. PubMed ID: 12777853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term experience of steroid-free pediatric renal transplantation: effects on graft function, body mass index, and longitudinal growth.
    Wittenhagen P; Thiesson HC; Baudier F; Pedersen EB; Neland M
    Pediatr Transplant; 2014 Feb; 18(1):35-41. PubMed ID: 24384046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up.
    Lee YJ; Kim B; Lee JE; Kim YG; Kim DJ; Kim SJ; Joh JW; Oh HY; Huh W
    Transpl Int; 2010 Feb; 23(2):147-54. PubMed ID: 19744223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-center experience in pediatric renal transplantation using thymoglobulin induction and steroid minimization.
    Warejko JK; Hmiel SP
    Pediatr Transplant; 2014 Dec; 18(8):816-21. PubMed ID: 25311592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of steroids and xenobiotic receptor polymorphisms in forecasting cyclosporine pharmacokinetic variability in young kidney transplant recipients.
    Ferraresso M; Turolo S; Belinghieri M; Tirelli AS; Grillo P; Groppali E; Edefonti A; Ghio L
    Pediatr Transplant; 2012 Sep; 16(6):658-63. PubMed ID: 22765024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal growth on an everolimus- versus an MMF-based steroid-free immunosuppressive regimen in paediatric renal transplant recipients.
    Billing H; Burmeister G; Plotnicki L; Ahlenstiel T; Fichtner A; Sander A; Höcker B; Tönshoff B; Pape L
    Transpl Int; 2013 Sep; 26(9):903-9. PubMed ID: 23865768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive therapy using CsA, MZ, steroids, and DSG during the early phase after kidney grafting, with later steroid withdrawal.
    Suzuki S; Hayashi R; Nakatani T; Amemiya H
    Transplant Proc; 1994 Aug; 26(4):2065-6. PubMed ID: 8066671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.